1. Xiaomu Kong;Zhaojun Yang;Bo Zhang;Xiaoping Chen; Liping Yu;Haiqing Zhu;Xiaoyan Xing;Wenying Yang*.Maternal and paternal histories differentially influence risks for diabetes, insulin secretion and insulin resistance in a Chinese population.J Diabetes Investig.2021.12(3).434-445.SCI |
2. Jianxin Li; Jing Li*;Zhongyan Shan; Wenying Yang;Jie Liu; Haoming Tian; Zhiguang Zhou; Qiuhe Ji; Jianping Weng;Weiping Jia;Juming Lu;Jing Liu;Yuan Xu;Zhaojun Yang.Gender-differential effects on blood glucose levels between acarbose and metformin in Chinese patients with newly diagnosed type 2 diabetes: a sub-analysis of the MARCH trial.Endocrine Journal.2021.68(1).69-79.SCI |
3. Lu-Lu Song;Xin Wang;Zhao-Jun Yang;Xiao-Mu Kong;Xiao-Ping Chen;Bo Zhang;Wen-Ying Yang.Factors associated with improvement in waist-to-height ratio among newly diagnosed type 2 diabetes patients treated with acarbose or metformin: A randomized clinical trial study.world Journal of diabetes.2020.11(11).514-526.SCI |
4. 王昕 杨兆军* 王娜.二甲双胍的降糖作用与腰围而非体质指数相关:MARCH研究亚组分析.中华糖尿病杂志.2018.10(2).773-776. |
5. Yang W, Yang Z. .Assessment of three fasting plasma glucose targets for insulin glargine-based therapy in people with type 2 diabetes mellitus in China: study protocol for a randomized controlled trial. .Trials.2016.17(1).470.SCI |
6. Zhang J, Yang Z#, Xiao J, Xing X, Lu J, Weng J, Jia W, Ji L, Shan Z, Liu J, Tian H, Ji Q, Zhu D, Ge J, Chen L, Guo X, Zhao Z, Li Q, Zhou Z, Lin L, Wang N, Yang W.Association between family history risk categories and prevalence of diabetes in Chinese population.Plos One.2015.10(2).e0117044.SCI |
7. Zhao-Jun Yang, Jie Liu#, Jia-Pu Ge, et al.Prevalence of cardiovascular disease risk factor in Chinese population: The 2007-2008 China National Diabetes and Metabolic Disorders Study.Eur Heart J.2012.33.213-220.SCI |
8. Wenying Yang, Jianzhong Xiao, Zhaojun Yang, et al..Serum Lipids and Lipoproteins in Chinese Men and Women.circulation.2012.125.2212-2221.SCI |
9. 杨兆军 单忠艳 田浩明 翁建平 周智广 杨文英.中国四省市阿司匹林预防心血管疾病用药现状调查.中华糖尿病杂志.2011.3(1).31. |